Renin-angiotensin-aldosterone inhibitors and COVID-19: nearing the end of a media-fuelled controversy

Tomasoni, D., Petrie, M. C. , Adamo, M. and Metra, M. (2021) Renin-angiotensin-aldosterone inhibitors and COVID-19: nearing the end of a media-fuelled controversy. European Journal of Heart Failure, 23(3), pp. 486-488. (doi: 10.1002/ejhf.2098) (PMID:33421242) (PMCID:PMC8013611)

Full text not currently available from Enlighten.

Abstract

No abstract available.

Item Type:Articles (Editorial)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Petrie, Professor Mark
Authors: Tomasoni, D., Petrie, M. C., Adamo, M., and Metra, M.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
Journal Name:European Journal of Heart Failure
Publisher:Wiley
ISSN:1388-9842
ISSN (Online):1879-0844
Published Online:09 January 2021

University Staff: Request a correction | Enlighten Editors: Update this record